Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Psychiatry Res
    April 2026
  1. DOHERTY E, Laighneach A, Casburn M, Quilligan F, et al
    Genetic studies of psychosocial disability establish correlations and causal relationships with neuropsychiatric disorders.
    Psychiatry Res. 2026;358:116963.
    >> Share

    February 2026
  2. BRENUGAT L, Mendy M, Maitre A, Danset C, et al
    Personalized approach to cognitive remediation for people with schizophrenia and autism.
    Psychiatry Res. 2026;359:117054.
    >> Share

  3. SHIZUKAWA K
    Letter to the Editor: Comment regarding "A comparative study of medication adherence in schizophrenia patients receiving clozapine and other antipsychotics".
    Psychiatry Res. 2026;359:117047.
    >> Share

  4. FUKUMOTO K, Ohi K, Ito S, Yasuda Y, et al
    Psychiatrists' adherence to guideline-recommended pharmacotherapy for schizophrenia affects subcortical structural alterations in the brains of patients with schizophrenia.
    Psychiatry Res. 2026;359:117050.
    >> Share

  5. TESSIER A, Fatseas M, Dansou Y, Godin O, et al
    Tobacco craving and suicidal risk in a cohort of subjects with schizophrenia: results from the national FACE-SZ cohort.
    Psychiatry Res. 2026;359:117028.
    >> Share

  6. ZHANG HM, Zhang YH
    Letter to the Editor regarding "Social networks and symptomatology in recently hospitalized individuals with schizophrenia-spectrum disorders: A six-month longitudinal study".
    Psychiatry Res. 2026;359:116997.
    >> Share

  7. OSTERGAARD SD, Speed M, Hall ASM, Agerbo E, et al
    Genetic liability to mental disorders and being delivered via cesarean section.
    Psychiatry Res. 2026;356:116871.
    >> Share

  8. REDLICH BOSSY M, Muller DR, Cecere G, Vetter S, et al
    Feasibility and efficacy of short cognitive remediation interventions for schizophrenia: a randomized active control trial.
    Psychiatry Res. 2026;356:116881.
    >> Share

  9. SANTANGELO G, Gnazzo M, Baldini V, De Ronchi D, et al
    Unraveling the gender divide: A systematic review of gender-specific differences at the first episode of psychosis.
    Psychiatry Res. 2026;356:116914.
    >> Share

  10. GARCIA-JIMENEZ J, Lafuente-Casanova O, Salas R, Rodriguez C, et al
    12-Month mirror study on the effectiveness and safety of six-month paliperidone palmitate in patients with schizophrenia: A Multicenter Andalusian Cohort (PAPSEM study).
    Psychiatry Res. 2026;356:116903.
    >> Share

  11. SWIECZKOWSKI D, Kwasny A, Cubala WJ
    Cross-sectional analysis of ongoing clinical trials involving lamotrigine for mental disorders: Insights from ClinicalTrials.gov and the EU clinical trials.
    Psychiatry Res. 2026;356:116878.
    >> Share

  12. BROWN WJ, Graziano RC, Babb ZA, Zampogna AM, et al
    Modeling the symptom connections between posttraumatic stress disorder and comorbid severe mental illness.
    Psychiatry Res. 2026;356:116861.
    >> Share

    January 2026
  13. LEE T, Choi BS, Kim JH
    Cumulative incidence of schizophrenia-spectrum disorders in children and adolescents with neurodevelopmental disorders: A retrospective cohort study.
    Psychiatry Res. 2026;358:116981.
    >> Share

  14. MUSTONEN A, Niemela S, Denissoff A, Forti MD, et al
    Optimizing antipsychotic dosing for relapse prevention in cannabis-induced psychosis: A nationwide cohort study.
    Psychiatry Res. 2026;358:116966.
    >> Share

  15. VERIM B, Demirlek C, Zorlu N, Erdeniz B, et al
    Transdiagnostic investigation of white matter integrity and cortical thickness in cognitive subgroups within the schizophrenia-bipolar spectrum.
    Psychiatry Res. 2026;358:116964.
    >> Share

  16. SCHOCK GV, Kittleson AR, Halverson AS, Liu J, et al
    Social networks and symptomatology in recently hospitalized individuals with schizophrenia-spectrum disorders: A six-month longitudinal study.
    Psychiatry Res. 2026;358:116960.
    >> Share

  17. LIN CH, Chiang CL, Yu DY, Horio H, et al
    Clinical remission, functional recovery, and employment in early-phase schizophrenia treated with paliperidone palmitate: An 18-month longitudinal Asia-Pacific study.
    Psychiatry Res. 2026;358:116955.
    >> Share

  18. ASENJO-LOBOS C, Arancibia M, Cortes-Jofre M, Huang T, et al
    Comparative efficacy and safety of clozapine and olanzapine in schizophrenia and related disorders: An updated systematic review.
    Psychiatry Res. 2026;358:116956.
    >> Share

  19. STABELL LA, Johnsen E, Kroken R, Loberg EM, et al
    Levels of and changes in psychosis symptoms and clinical insight: Exploring the impact of differential antipsychotic mechanisms.
    Psychiatry Res. 2026;358:116948.
    >> Share

  20. VAN BUITENEN N, van den Berg C, Meijers J, Harte J, et al
    Prevalence and patterns of comorbid mental disorders in a male forensic psychiatric sample: A network analysis.
    Psychiatry Res. 2026;355:116847.
    >> Share

  21. GRAUX J, Thillay A, Sommer J, Morel-Kohlmeyer S, et al
    The ANCog: A French self-report scale for assessing subjective cognitive complaints in rehabilitation samples.
    Psychiatry Res. 2026;355:116830.
    >> Share

    December 2025
  22. GRECA E, Belalcazar-Vivas V, Ferrer GF, Michel JJ, et al
    SHAPING MINDS: A systematic review and meta-analysis on the effects of structured exercise in schizophrenia spectrum disorders.
    Psychiatry Res. 2025;357:116919.
    >> Share

  23. HUANG J, Xu J, Zhao Y, Zhang M, et al
    Analysis of language patterns in schizophrenia based on natural language processing.
    Psychiatry Res. 2025;356:116894.
    >> Share

  24. SMIECINSKA J, Sakson-Obada O
    Linguistic prosody perception in schizophrenia patients.
    Psychiatry Res. 2025;356:116899.
    >> Share

  25. LIANG M, Wang J, Zhao W
    Effectiveness of visual-based interventions for ameliorating theory of mind-related impairments in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2025;356:116891.
    >> Share

  26. CHANALIA S, Grover S, Chakrabarti S
    A comparative study of medication adherence in schizophrenia patients receiving clozapine and other antipsychotics.
    Psychiatry Res. 2025;358:116879.
    >> Share

  27. PUZIA M, Stokes B, Oh HY, Anglin DM, et al
    Reasons for discrimination and mental health symptoms among ethnoracially diverse individuals in the early stages of psychosis.
    Psychiatry Res. 2025;356:116869.
    >> Share

  28. BERTRAND CE, Pokorny V, Foti D, Osborne KJ, et al
    Neural correlates of conversational turn-taking perception in individuals at clinical high-risk for psychosis.
    Psychiatry Res. 2025;356:116870.
    >> Share

  29. DIELEMANS DAM, Hagen JM, Sutterland AL, Bourgonje AR, et al
    Systemic inflammatory and oxidative stress alterations in recent-onset psychosis: findings from a non-smoking case-control sample.
    Psychiatry Res. 2025;356:116866.
    >> Share

    November 2025
  30. CHEN H, Li J, Jia X, Wang X, et al
    Efficacy of high-frequency transcranial magnetic stimulation to improve negative symptoms in patients with Schizophrenia: A meta-analysis of randomized controlled trials.
    Psychiatry Res. 2025;356:116868.
    >> Share

  31. HOWIE JH, Fielden CR, Rempfer MV
    Cognition in schizophrenia across phases of illness: A systematic review and meta-analysis.
    Psychiatry Res. 2025;355:116856.
    >> Share

  32. OSTOJIC D, Quilligan F, Cannon DM, Madden MG, et al
    Machine learning identifies traumatic experiences as being associated with auditory verbal hallucinations in both a non-clinical population and individuals diagnosed with psychosis.
    Psychiatry Res. 2025;356:116854.
    >> Share

  33. SAKA IM, Arslan FC, Demir S, Mentese A, et al
    The relationship between serum Interleukin- 6, Interleukin- 18, Interleukin- 2, Eotaxin-1, Monocyte Chemoattractant Protein 1 levels and cognitive functions in treatment-resistant schizophrenia.
    Psychiatry Res. 2025;355:116835.
    >> Share

  34. SUN A, Eakins RE, Gozlan EC, Chobrutskiy A, et al
    A quantitative assessment of TRB CDR3-CMV antigen chemical interactions distinguishes schizophrenia patients in case/control comparisons.
    Psychiatry Res. 2025;355:116834.
    >> Share

  35. MIZUTANI R, Saiga R, Yamamoto Y, Inomoto C, et al
    Pyramidal soma size in the anterior cingulate cortex is small in schizophrenia and correlates with hallucination score.
    Psychiatry Res. 2025;355:116822.
    >> Share

  36. CELIC RUZIC M, Zarkovic N, Rossini Gajsak L, Filipcic I, et al
    Persistent oxidative stress and functional outcomes in early psychosis: A longitudinal study.
    Psychiatry Res. 2025;354:116818.
    >> Share

  37. NADER G, Ducharme M, Torres-Carmona E, Fischer C, et al
    A novel method of measuring cortical thickness in schizophrenia spectrum disorders: a preliminary analysis of multi-echo fast spoiled gradient echo MRI.
    Psychiatry Res. 2025;356:116817.
    >> Share

    October 2025
  38. GUO X, Wu S, Jia T, Sun Z, et al
    Plasma fatty acids levels and risk of schizophrenia in the UK Biobank: a prospective cohort study.
    Psychiatry Res. 2025;354:116805.
    >> Share

  39. VERDAGUER-RODRIGUEZ M, Lopez-Carrilero R, Diaz-Cutraro L, Ferrer-Quintero M, et al
    Sex-based differences in neurocognitive functioning in first-episode psychosis: An exploratory analysis.
    Psychiatry Res. 2025;354:116803.
    >> Share

  40. DELISI LE
    Reflections from half a century of progress searching for the causes of schizophrenia: Stanley Dean award presentation 2025.
    Psychiatry Res. 2025;354:116790.
    >> Share

  41. HU G, Wei D, Zhang J, Liu J, et al
    Effect of computerized cognitive remediation therapy combined with individualized occupational therapy on cognitive function and functional outcomes in patients with schizophrenia: A randomized controlled trial.
    Psychiatry Res. 2025;354:116789.
    >> Share

  42. ZENCIR T, Celik Zencir A, Tekinarslan G, Koc M, et al
    The role of socioeconomic and structural vulnerability risk factors in employment outcomes for individuals with Schizophrenia and other psychotic disorders.
    Psychiatry Res. 2025;354:116782.
    >> Share

  43. LEIJALA J, Kampman O, Gunnar T, Suvisaari J, et al
    Treatment adherence in first-episode psychosis: A one-year follow-up study comparing self-reported adherence, pharmacy refill data, and therapeutic drug monitoring.
    Psychiatry Res. 2025;354:116780.
    >> Share

  44. MUELLER N, Mulfarth R, Seuffert S, Dannlowski U, et al
    Figurative language production in schizophrenia, bipolar disorder, and depression.
    Psychiatry Res. 2025;354:116772.
    >> Share

  45. ASENJO-LOBOS C, Arancibia M, Garcia-Ribera C, Cortes-Jofre M, et al
    Comparative efficacy and safety of Clozapine vs. Quetiapine in schizophrenia and related disorders: An updated systematic review.
    Psychiatry Res. 2025;353:116764.
    >> Share

  46. PREOBRAZENSKI N, Hsieh T, Robertson C, Thai H, et al
    Polypharmacy in clozapine-treated patients: A retrospective analysis of 667 patients in Ottawa, Canada.
    Psychiatry Res. 2025;352:116684.
    >> Share

  47. XUE J, Zhai Z, Li X, Zhu Y, et al
    Deep transcranial magnetic stimulation over the anterior cingulate cortex in treatment-resistant schizophrenia: A pilot double-blind, randomized controlled trial.
    Psychiatry Res. 2025;353:116756.
    >> Share

    September 2025
  48. PANGANIBAN KJ, Smith ECC, Stogios N, Agarwal SM, et al
    The cognitive metabolomic signatures in schizophrenia spectrum disorders: A systematic review.
    Psychiatry Res. 2025;353:116742.
    >> Share

  49. MONTI P, Iodice S, Capuzzi E, Borroni E, et al
    Short-term exposure to particulate matter and apparent temperature is associated with schizophrenia severity in Italy.
    Psychiatry Res. 2025;353:116735.
    >> Share

  50. SOTERO-MORENO A, Guardiola-Ripoll M, Hostalet N, Moreira M, et al
    Effects of DISC1 and hypoxia-sensitive genes on dermatoglyphics and cognitive function in schizophrenia.
    Psychiatry Res. 2025;353:116721.
    >> Share

  51. BIAGETTI R, Caiazza L, Giuva T, Pirani G, et al
    Clozapine-induced cardiac toxicity and successful rechallenge in children and adolescents: a systematic review and new case report.
    Psychiatry Res. 2025;351:116646.
    >> Share

  52. GOMBAS SA, Moran EK, Barch DM
    Relationships between cognition and symptoms across mood and psychotic disorders.
    Psychiatry Res. 2025;351:116628.
    >> Share

  53. ZHU T, Jiao X, Zhou J, Nicholas PJ, et al
    Efficacy of rTMS on SCZ symptoms: Insights from connectome mapping.
    Psychiatry Res. 2025;351:116568.
    >> Share

  54. LU N, Wang M, Zheng Z, Zhang F, et al
    Comorbidity of common psychiatric disorders and attention-deficit/hyperactivity disorder in Chinese adults.
    Psychiatry Res. 2025;351:116662.
    >> Share

    August 2025
  55. PATEL SES, Haut KM, Lee H, Fisher M, et al
    Social cognition training improves recognition of individual emotions in schizophrenia disorder.
    Psychiatry Res. 2025;352:116711.
    >> Share

  56. BLAIN SD, Kent JS, Peyromaure de Bord CA, Sponheim SR, et al
    Social cognitive deficits in schizophrenia, bipolar disorder, and first-degree relatives: A large-sample, multi-task investigation.
    Psychiatry Res. 2025;352:116694.
    >> Share

  57. JUST SA, Elvevag B, Pandey S, Nenchev I, et al
    Moving beyond word error rate to evaluate automatic speech recognition in clinical samples: Lessons from research into schizophrenia-spectrum disorders.
    Psychiatry Res. 2025;352:116690.
    >> Share

  58. WANG Z, Li J, Wang L, Wei Q, et al
    Comparative Effects of Exercise Modalities on Negative Symptoms in Schizophrenia: A Systematic Review and Network Meta-analysis of 32 RCTs.
    Psychiatry Res. 2025;352:116665.
    >> Share

  59. ASENJO-LOBOS C, Arancibia M, Cortes-Jofre M, Huang T, et al
    Comparative efficacy and safety of clozapine vs. risperidone in schizophrenia and related disorders: An updated systematic review.
    Psychiatry Res. 2025;351:116670.
    >> Share

    July 2025
  60. DUDLEY R, White S, Miskin R, Oakes L, et al
    Corrigendum to Hallucinations across sensory domains in people with post-traumatic stress disorder and psychosis, Psychiatry Research, Vol 342, December 2024, 116229.
    Psychiatry Res. 2025;351:116642.
    >> Share

  61. ARSLAN B, Kizilay E, Turan YE, Verim B, et al
    Computational linguistic investigation in schizophrenia and autism spectrum disorders.
    Psychiatry Res. 2025;351:116633.
    >> Share

  62. LEATHEM LD, Barch DM, Moran EK, Patel PK, et al
    Cognitive effort-based decision making in schizophrenia and bipolar disorder: Associations with clinical symptoms and cognitive performance.
    Psychiatry Res. 2025;351:116629.
    >> Share

  63. CHIU EC, Lee SC
    Effect of community-based reablement program on quality of life for people with schizophrenia: A randomized controlled study.
    Psychiatry Res. 2025;351:116624.
    >> Share

    June 2025
  64. STUDART I, Rasmussen AR
    OCD with psychotic features or schizophrenia with obsessions and compulsions?
    Psychiatry Res. 2025;351:116619.
    >> Share

  65. SUN X, Qiu Y, Ji L, Li M, et al
    Proteomic characterization of plasma exosomes in drug-naive schizophrenia: Insights into psychosis and cognitive dysfunction.
    Psychiatry Res. 2025;351:116611.
    >> Share

  66. SU Q, Wang J, Ge H, Li M, et al
    The relationship between inflammation and cognitive function in drug-naive schizophrenia with or without pre-metabolic syndrome.
    Psychiatry Res. 2025;351:116604.
    >> Share

  67. KOTWANI A, Wojtalik JA, Gunzler DD, Smith MJ, et al
    Social cognition as a mediator between neurocognition and functional outcome in early course schizophrenia.
    Psychiatry Res. 2025;351:116594.
    >> Share

  68. JACOBSEN SL, Kohler-Forsberg O, Danielsen AA, Rohde C, et al
    Efficacy and safety of GLP1-ras compared to SGLT2is and DPP-4is in individuals with schizophrenia and diabetes: A Danish nationwide target-trial emulation study.
    Psychiatry Res. 2025;351:116592.
    >> Share

  69. AL-KURAISHY HM, Mohammed HA, Sulaiman GM, Jabir MS, et al
    Targeting of inflammation and prostaglandins by nonsteroidal anti-inflammatory drugs in schizophrenia: A narrative review.
    Psychiatry Res. 2025;351:116575.
    >> Share

    May 2025
  70. PILON F, Boisvert M, Mottron L, Potvin S, et al
    A fMRI meta-analysis of emotion processing in the psychosis spectrum reveals no significant alterations in at-risk individuals.
    Psychiatry Res. 2025;351:116565.
    >> Share

  71. DODGSON G, Singh A, Barclay N, Birkett L, et al
    Managing unusual sensory experiences in at-risk mental state for psychosis in England: A parallel group, single-blind, randomised controlled feasibility trial.
    Psychiatry Res. 2025;351:116564.
    >> Share

  72. SAITOH K, Lajnef M, Boukouaci W, Andre M, et al
    Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohort.
    Psychiatry Res. 2025;350:116557.
    >> Share

  73. CHEN B, Tan XW, Tor PC
    Effects of dose on early treatment response to bifrontal electroconvulsive therapy in Schizophrenia: A retrospective study.
    Psychiatry Res. 2025;350:116554.
    >> Share

  74. CORONADO-MONTOYA S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, et al
    A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis.
    Psychiatry Res. 2025;350:116553.
    >> Share

  75. TOTZEK JF, Shah JL, Young AL, Malla A, et al
    From resting-state functional hippocampal centrality to functional outcome: An extended neurocognitive model of psychosis.
    Psychiatry Res. 2025;350:116538.
    >> Share

  76. GUTIERREZ G, Garcia de Jalon E, Aranguren L, Corrales A, et al
    Corrigendum to 'Antipsychotic discontinuation in nonaffective first-episode psychosis after clinical remission: Insights from the PEPsNa naturalistic study' [ Psychiatry Research volume 342 (December 2024) 1-10/116261].
    Psychiatry Res. 2025 May 16:116539. doi: 10.1016/j.psychres.2025.116539.
    >> Share

  77. LUO H, Li YL, Luo XJ, Xia L, et al
    The efficacy of psychoeducation-based programs on internalized stigma in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2025;350:116540.
    >> Share

  78. HOFMANN AB, Dorner M, Klassen PE, Machetanz L, et al
    RIPTOSO: The development of a screening tool for adverse events during forensic-psychiatric inpatient treatments of offenders with schizophrenia spectrum disorders.
    Psychiatry Res. 2025;350:116537.
    >> Share

  79. BERE M, Rossell SL, Toh WL
    Corrigendum to Cognition in relation to non-auditory or multisensory hallucinations in schizophrenia-spectrum disorders: A scoping review.
    Psychiatry Res. 2025;349:116526.
    >> Share

  80. PERALTA V, de Jalon EG, Moreno-Izco L, Peralta D, et al
    Corrigendum to 'A clinical staging model of psychotic disorders based on a long-term follow-up of first-admission psychosis: A validation study' Psychiatry Res. 2023; 322:115109.
    Psychiatry Res. 2025;349:116530.
    >> Share

    April 2025
  81. DEMIRLI E, Ahmed AO, Serper M
    Personal recovery and future self-continuity in individuals with schizophrenia.
    Psychiatry Res. 2025;348:116510.
    >> Share

  82. PELIZZA L, Leuci E, Quattrone E, Palmisano D, et al
    Compulsory admission as access to early intervention service for patients with first episode psychosis: What relevance for clinical outcomes? Further findings from the Pr-EP program.
    Psychiatry Res. 2025;349:116507.
    >> Share

  83. SALGADO-PINEDA P, Barbosa L, Hostalet N, Garcia-Leon MA, et al
    An ontogenetic role for Broca's and related speech areas in schizophrenic auditory hallucinations? Evidence from sulcal pits analysis.
    Psychiatry Res. 2025;348:116502.
    >> Share

  84. CAO C, Liu W, Hou C, Chen Y, et al
    Disrupted default mode network connectivity and its role in negative symptoms of schizophrenia.
    Psychiatry Res. 2025;348:116489.
    >> Share

  85. LU J, Gou N, Zhang S, Zhou J, et al
    Dysfunctional striatal-temporal connectivity is associated with a higher risk for violence in patients with schizophrenia.
    Psychiatry Res. 2025;348:116488.
    >> Share

    March 2025
  86. SIMGE UO, Burcu V, Aybuke K, Ezgi C, et al
    Clinical high risk for psychosis in bipolar disorder: Clinical features, cognition and functioning.
    Psychiatry Res. 2025;348:116478.
    >> Share

  87. SHAKER NM, Aly El-Gabry D, Abdel Aziz K, Hashem R, et al
    Clinical and neuroradiological differences in obsessive compulsive disorder with and without psychosis.
    Psychiatry Res. 2025;348:116472.
    >> Share

  88. KANE JM, Rubio JM, Casciano J, Dotiwala Z, et al
    Real-world outcomes and practice patterns among patients with schizophrenia when switched from oral antipsychotics to long-acting injectable formulations after hospitalization.
    Psychiatry Res. 2025;348:116455.
    >> Share

  89. APRILE SF, Rodolico A, Di Francesco A, Varrasi S, et al
    Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: A systematic review of patients' subjective experiences.
    Psychiatry Res. 2025;348:116460.
    >> Share

  90. LINDSTROM S, Nordgaard J, Berge J
    Transition from schizotypal disorder to non-affective psychotic disorders including schizophrenia: A nationwide Swedish cohort study.
    Psychiatry Res. 2025;348:116470.
    >> Share

  91. BAILEY A, Bauer BW, Mittal VA, Ellman LM, et al
    Interpersonal difficulties and suicidal ideation in young people at clinical high-risk for psychosis and help-seeking clinical controls.
    Psychiatry Res. 2025;348:116467.
    >> Share

  92. NEERGAARD KD, Zemla JC, Victor Ortiz-Garcia de la F, Lubrini G, et al
    Novel computational measure of semantic fluency performance associated with first-episode of psychosis.
    Psychiatry Res. 2025;348:116462.
    >> Share

  93. SUDAR FP, Zekerallah SS, Paulzen M, Mathiak K, et al
    Unraveling antipsychotic induced weight gain in schizophrenia - A proof-of-concept study exploring the impact of the cumulative historical occupancy of different receptors by antipsychotics.
    Psychiatry Res. 2025;348:116452.
    >> Share

  94. SHIMADA T, Ito S, Yamanushi A, Koizumi A, et al
    Effect of aerobic exercise versus cognitive remediation versus a combination of both on cognition among patients with schizophrenia: A three-arm, randomized controlled study.
    Psychiatry Res. 2025;348:116454.
    >> Share

  95. GOLDSTEIN KE, Pietrzak RH, Aladin S, Ng S, et al
    Neuro- and social-cognition in schizotypal personality disorder and schizophrenia: A spectrum of severity.
    Psychiatry Res. 2025;348:116445.
    >> Share

  96. MEWENGKANG A, Pandolos T, Sengkey MM, Sengkey SB, et al
    Sleep quality vs. mental health: A complex relationship with psychosis.
    Psychiatry Res. 2025;348:116441.
    >> Share

  97. SENTHIL KUMAR L, Chen B, Tan X, Tor PC, et al
    Response to electroconvulsive therapy is not consistently replicated across multiple treatment courses.
    Psychiatry Res. 2025;345:116374.
    >> Share

  98. LOHMAN MC, Scott V, Verma M, Jones P, et al
    Distribution and correlates of long-acting injectable antipsychotic use among community mental health center patients.
    Psychiatry Res. 2025;345:116378.
    >> Share

    February 2025
  99. SOLBERG A, Ottesen A, Barrett EA, Kristiansen I, et al
    Trajectories of suicidal behavior and their clinical correlates in the early phases of schizophrenia spectrum disorders.
    Psychiatry Res. 2025;347:116409.
    >> Share

  100. DAMIANI S, D'Imperio A, Radua J, Fortea L, et al
    A systematic review and synthesis of 489 studies investigating treatments for negative symptoms in the schizophrenia spectrum: Trial designs, demographics and clinical characteristics.
    Psychiatry Res. 2025;347:116406.
    >> Share

  101. CAI C, Zhao P, Patel C, Benson C, et al
    Latent variable analysis of adherence to antipsychotics among south carolina medicaid beneficiaries with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2025;346:116402.
    >> Share

  102. HANDEST R, Molstrom IM, Henriksen MG, Nordgaard J, et al
    Revisiting the relationship between impaired social functioning and psychopathology in schizophrenia.
    Psychiatry Res. 2025;346:116389.
    >> Share

    January 2025
  103. HUIZER K, Soni S, Schmidt MA, Cakici N, et al
    Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophrenia.
    Psychiatry Res. 2025;345:116379.
    >> Share

  104. HWANG H, Kim SM, Kim HJ, Han DH, et al
    Comparison of attention and brain functional connectivity between patient groups with schizophrenia and attention deficit hyperactivity disorder.
    Psychiatry Res. 2025;345:116376.
    >> Share

  105. BERISHA F, Paquin V, Gold I, Misic B, et al
    Exploring delusional themes and other symptoms in first episode psychosis: A network analysis over two timepoints.
    Psychiatry Res. 2025;344:116349.
    >> Share

  106. GRENDAS LN, Olaviaga A, Chiapella LC, Daray FM, et al
    Incidence rate of suicidal behavior stratified by diagnosis among high-risk patients.
    Psychiatry Res. 2025;343:116310.
    >> Share

    December 2024
  107. LI J, He J, Ren H, Li Z, et al
    Multilayer network instability underlying persistent auditory verbal hallucinations in schizophrenia.
    Psychiatry Res. 2024;344:116351.
    >> Share

  108. ZHANG H, He R, Palominos C, Hsu N, et al
    The structure of meaning in schizophrenia: A study of spontaneous speech in Chinese.
    Psychiatry Res. 2024;344:116347.
    >> Share

  109. HSIAO CY, Wu KY, Chiu CK, Lu HL, et al
    Development and validation of a schizophrenia literacy scale for individuals diagnosed with schizophrenia.
    Psychiatry Res. 2024;344:116344.
    >> Share

  110. PIETERS LE, Deenik J, Hoogendoorn AW, van Someren EJW, et al
    Sleep and physical activity patterns in relation to daily-life symptoms in psychosis: An actigraphy and experience sampling study.
    Psychiatry Res. 2024;344:116320.
    >> Share

  111. GARCIA-FERNANDEZ L, Romero-Ferreiro V, Padilla S, Wynn R, et al
    Transcranial direct current stimulation (tDCS) enhances cognitive function in schizophrenia: A randomized double-blind sham-controlled trial.
    Psychiatry Res. 2024;344:116308.
    >> Share

  112. WYSOKINSKI A, Dreczka J
    Clozapine Toxicity Predictor: Deep neural network model predicting clozapine toxicity and its therapeutic dose range.
    Psychiatry Res. 2024;342:116256.
    >> Share

  113. SOLDEVILA-MATIAS P, Sanchez-Orti JV, Correa-Ghisays P, Balanza-Martinez V, et al
    Exercise as a promoter of neurocognitive improvement in people with psychiatric disorders and comorbid obesity: A randomized controlled trial.
    Psychiatry Res. 2024;342:116226.
    >> Share

  114. FLORENTIN S, Neumark Y, Roe D, Rosca P, et al
    The relationship between community-based psychiatric rehabilitation pathways and re-hospitalization trajectories: A three-decade follow-up.
    Psychiatry Res. 2024;342:116216.
    >> Share

  115. PISANU C, Congiu D, Meloni A, Paribello P, et al
    Sex differences in shared genetic determinants between severe mental disorders and metabolic traits.
    Psychiatry Res. 2024;342:116195.
    >> Share

    November 2024
  116. SOURANDER A, Silwal S, Surcel HM, Hinkka-Yli-Salomaki S, et al
    Maternal vitamin B12 during pregnancy and schizophrenia in offspring.
    Psychiatry Res. 2024;344:116284.
    >> Share

  117. MORITZ S, Leucht S, Hoyer L, Schmotz S, et al
    Towards the DSM-6: The intersection of OCD and psychosis. Expert perspectives on insight in the diagnosis of OCD.
    Psychiatry Res. 2024;344:116306.
    >> Share

  118. KHOODORUTH MAS, Hussain T, Ouanes S, Chut-Kai Khoodoruth NW, et al
    Peripheral inflammatory and metabolic markers as potential biomarkers in treatment-resistant schizophrenia: Insights from a Qatari Cohort.
    Psychiatry Res. 2024;344:116307.
    >> Share

  119. KUMAR M, Choudhary H, Chawla N
    Association of antipsychotic formulations with sudden cardiac death in patients with schizophrenia: A nationwide population-based case-control study: Letter to the editor.
    Psychiatry Res. 2024;343:116299.
    >> Share

  120. GONCALVES CC, Waters Z, Quirk SE, Haddad PM, et al
    Barriers and facilitators to mental health care access and engagement for LGBTQA+ people with psychosis: A scoping review.
    Psychiatry Res. 2024;343:116281.
    >> Share

  121. REANGSING C, Wongsuraprakit S, Punsuwun S, Oerther S, et al
    Effects of mindfulness-based interventions (MBIs) on psychotic symptoms and psychological outcomes in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis.
    Psychiatry Res. 2024;342:116272.
    >> Share

  122. LAMARCA M, Espinosa V, Acuna V, Vila-Badia R, et al
    Reducing self-stigma in psychosis: A systematic review and meta-analysis of psychological interventions.
    Psychiatry Res. 2024;342:116262.
    >> Share

  123. BERE M, Rossell SL, Toh WL
    Cognition in relation to non-auditory or multisensory hallucinations in schizophrenia-spectrum disorders: A scoping review.
    Psychiatry Res. 2024;342:116268.
    >> Share

  124. ABRAHAM T, Gill H, Wood L
    Psychosocial interventions offered across inpatient and crisis settings to the social networks of service users with psychosis: A systematic review.
    Psychiatry Res. 2024;343:116267.
    >> Share

  125. GUTIERREZ G, Garcia de Jalon E, Aranguren L, Corrales A, et al
    Antipsychotic discontinuation in nonaffective first-episode psychosis after clinical remission: Insights from the PEPsNa naturalistic study.
    Psychiatry Res. 2024;342:116261.
    >> Share

  126. PUGH SL, Chandler C, Cohen AS, Diaz-Asper C, et al
    Assessing dimensions of thought disorder with large language models: The tradeoff of accuracy and consistency.
    Psychiatry Res. 2024;341:116119.
    >> Share

    October 2024
  127. CALZAVARA PINTON I, Nibbio G, Bertoni L, Cicale A, et al
    The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study.
    Psychiatry Res. 2024;342:116240.
    >> Share

  128. DEMIRLEK C, Verim B, Zorlu N, Demir M, et al
    Functional brain networks in clinical high-risk for bipolar disorder and psychosis.
    Psychiatry Res. 2024;342:116251.
    >> Share

  129. KISIANG'ANI IB, Aden M, Mwangi HR, Akena D, et al
    Exploring psychotic symptoms among substance-naive individuals and recent abstainers without a psychosis diagnosis: A cross-country study across Kenya, Uganda, Ethiopia, and South Africa.
    Psychiatry Res. 2024;342:116253.
    >> Share

  130. THIBAUDEAU E, Bowie CR, Montreuil T, Baer L, et al
    Acceptability, engagement, and efficacy of cognitive remediation for cognitive outcomes in young adults with first-episode psychosis and social anxiety: A randomized-controlled trial.
    Psychiatry Res. 2024;342:116243.
    >> Share

  131. GONZALES L, Saperstein AM, Qian M, Gorecki A, et al
    Psychiatric and functional correlates of stigma associated with cognitive impairment in schizophrenia.
    Psychiatry Res. 2024;342:116233.
    >> Share

  132. CIOFFI L, Wein PY, Miller SA, Fagan S, et al
    Clinical, neurocognitive, neurobiological and functional correlates of sleep difficulties in individuals at-risk for psychosis and mania: A scoping review.
    Psychiatry Res. 2024;342:116235.
    >> Share

  133. DUDLEY R, White S, Miskin R, Oakes L, et al
    Hallucinations across sensory domains in people with post-traumatic stress disorder and psychosis.
    Psychiatry Res. 2024;342:116229.
    >> Share

  134. TORREY EF, Simmons W, Dailey L
    Schizophrenia, clinical and basic research at NIMH: A 75 Year retrospective.
    Psychiatry Res. 2024;342:116225.
    >> Share

  135. SARNYAI Z, Ben-Shachar D
    Schizophrenia, a disease of impaired dynamic metabolic flexibility: A new mechanistic framework.
    Psychiatry Res. 2024;342:116220.
    >> Share

  136. BERA S, Yang AB, Chung D, Arnesen R, et al
    Duffy-null associated neutrophil count and antipsychotic use.
    Psychiatry Res. 2024;340:116146.
    >> Share

    September 2024
  137. ARMARIO A, Nadal R, Fuentes S, Visa J, et al
    Prenatal immune activation in rats and adult exposure to inescapable shocks reveal sex-dependent effects on fear conditioning that might be relevant for schizophrenia.
    Psychiatry Res. 2024;342:116219.
    >> Share

  138. GIAMPETRUZZI E, Walker EF, Addington J, Bearden CE, et al
    Impact of adverse childhood experiences on risk for internalizing psychiatric disorders in youth at clinical high-risk for psychosis.
    Psychiatry Res. 2024;342:116214.
    >> Share

  139. TEYMOURI K, Ebrahimi M, Chen CC, Sriretnakumar V, et al
    Sex-dependent association study of complement C4 gene with treatment-resistant schizophrenia and hospitalization frequency.
    Psychiatry Res. 2024;342:116202.
    >> Share

  140. SUKNO FM, Kelly BD, Lane A, Katina S, et al
    Loss of normal facial asymmetry in schizophrenia and bipolar disorder: Implications for development of brain asymmetry in psychotic illness.
    Psychiatry Res. 2024;342:116213.
    >> Share

  141. CIUFALO J, Zaccone S, Fatiga G, Caputo GB, et al
    Creative puppet therapy reduces hallucinations in patients diagnosed with schizophrenia: Preliminary findings.
    Psychiatry Res. 2024;342:116211.
    >> Share

  142. GLINERT A, Zlidennyy V, Turjeman S, Sharon E, et al
    What's GABA got to do with it? A potential link between the microbiome, schizophrenia, and the endo-cannabinoid system.
    Psychiatry Res. 2024;342:116196.
    >> Share

  143. DOMINGUEZ T, Puebla DP, Fresan A, Sheinbaum T, et al
    Why do some Mexicans with psychosis risk symptoms seek mental health care and others do not?
    Psychiatry Res. 2024;342:116199.
    >> Share

  144. CASANOVAS F, Dinamarca F, Posso M, Mane A, et al
    Cancer characteristics in patients with schizophrenia: a 25-year retrospective analysis.
    Psychiatry Res. 2024;342:116206.
    >> Share

  145. MEHTA UM, Roy N, Bahuguna A, Kotambail A, et al
    Incremental predictive value of genetic risk and functional brain connectivity in determining antipsychotic response in schizophrenia.
    Psychiatry Res. 2024;342:116201.
    >> Share

  146. TANG JMY, Chiu KKY, Yang C, Cheung DSK, et al
    Social cognition interventions for patients with first-episode psychosis: A scoping review.
    Psychiatry Res. 2024;342:116191.
    >> Share

  147. KRISTENSEN TD, Mager FM, Ambrosen KS, Barber AD, et al
    Cognitive profiles across the psychosis continuum.
    Psychiatry Res. 2024;342:116168.
    >> Share

  148. D'ANDREA G, Ouellet-Plamondon C, Villeneuve M, Shah JL, et al
    Joint-trajectories of clinical severity, social functioning and cannabis use in first-episode psychosis: A 5-year longitudinal study in 2 urban early intervention services.
    Psychiatry Res. 2024;342:116184.
    >> Share

  149. VALT C, Lopez-Caballero F, Tavella A, Altamura M, et al
    Abnormal inter-hemispheric effective connectivity from left to right auditory regions during Mismatch Negativity (MMN) tasks in psychosis.
    Psychiatry Res. 2024;342:116189.
    >> Share

  150. BORNHEIMER LA, Bagge CL, Overholser J, Brdar NM, et al
    Demographic and clinical characteristics of individuals with psychosis symptoms who died by suicide: Findings of a psychological autopsy study.
    Psychiatry Res. 2024;342:116185.
    >> Share

  151. HSIEH KP, Liao WL, Ho PS, Lin JW, et al
    Association of antipsychotic formulations with sudden cardiac death in patients with schizophrenia: A nationwide population-based case-control study.
    Psychiatry Res. 2024;342:116171.
    >> Share

  152. DE HAAS HJ, Cohen D, de Koning MB, van Weringh G, et al
    Clozapine levels and outcomes in Serbian patients with treatment-resistant psychotic disorders previously treated without measuring clozapine levels (CLOSER).
    Psychiatry Res. 2024;339:116070.
    >> Share

  153. PICCHIONI M, Ruiz R, de Girolamo G, Iozzino L, et al
    The predictive validity and temporal characteristics of the HCR-20v3 for inpatient violence in forensic inpatient settings. An international study.
    Psychiatry Res. 2024;339:116079.
    >> Share

  154. ZACHOS KA, Choi J, Godin O, Chernega T, et al
    Mitochondrial Biomarkers and Metabolic Syndrome in Bipolar Disorder.
    Psychiatry Res. 2024;339:116063.
    >> Share

  155. LUYKX JJ, Tanskanen A, Lahteenvuo M, Manu P, et al
    Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking.
    Psychiatry Res. 2024;339:116012.
    >> Share

    August 2024
  156. MORKVED N, Johnsen E, Kroken RA, Joa I, et al
    Childhood trauma types in relation to antipsychotic effectiveness in schizophrenia spectrum disorders: A prospective, pragmatic, randomized controlled study.
    Psychiatry Res. 2024;341:116169.
    >> Share

  157. SNELLEKSZ M, Dean B
    Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptors.
    Psychiatry Res. 2024;341:116156.
    >> Share

  158. MORO L, Sicotte R, Joober R, Malla A, et al
    Trajectories of suicidality during a 2-year early-intervention program for first-episode psychosis: A longitudinal study.
    Psychiatry Res. 2024;340:116148.
    >> Share

  159. COHEN S, Goldsmith DR, Ning CS, Addington J, et al
    Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosis.
    Psychiatry Res. 2024;341:116147.
    >> Share

  160. TSUI HKH, Luk SL, Hsiao J, Chan SKW, et al
    Facial emotion perception in individuals with clinical high risk for psychosis compared with healthy controls, first-episode psychosis, and in predicting psychosis transition: A systematic review and meta-analysis.
    Psychiatry Res. 2024;340:116143.
    >> Share

  161. GUZMAN A, Klein H, Keefe RS, Horan WP, et al
    Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls.
    Psychiatry Res. 2024;340:116121.
    >> Share

  162. GIANNOUCHOS TV, Ohsfeldt RL, Kum HC
    Trends and disparities in emergency department visits for schizophrenia spectrum disorders in Texas from 2019 to 2022.
    Psychiatry Res. 2024;340:116139.
    >> Share

  163. MENDEZ-VICTORIANO G, Zhu Y, Middleton F, Massa PT, et al
    Increased Parenchymal Macrophages are associated with decreased Tyrosine Hydroxylase mRNA levels in the Substantia Nigra of people with Schizophrenia and Bipolar Disorder.
    Psychiatry Res. 2024;340:116141.
    >> Share

  164. VITA G, Pollini D, Canozzi A, Papola D, et al
    Efficacy and acceptability of long-acting antipsychotics in acutely ill individuals with schizophrenia-spectrum disorders: A systematic review and network meta-analysis.
    Psychiatry Res. 2024;340:116124.
    >> Share

  165. VITA A, Nibbio G, Barlati S
    Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia.
    Psychiatry Res. 2024;340:116126.
    >> Share

    July 2024
  166. MAZZAROTTO F, Monteleone P, Minelli A, Mattevi S, et al
    Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis.
    Psychiatry Res. 2024;340:116107.
    >> Share

  167. GREVE AN, Hemager N, Mortensen EL, Gantriis DL, et al
    Comparing cognition in parents with schizophrenia or bipolar disorder and their 7-year-old offspring.
    Psychiatry Res. 2024;340:116112.
    >> Share

  168. LUCARINI V, Grice M, Wehrle S, Cangemi F, et al
    Language in interaction: turn-taking patterns in conversations involving individuals with schizophrenia.
    Psychiatry Res. 2024;339:116102.
    >> Share

  169. BLOSE BA, Silverstein SM, Stuart KV, Keane PA, et al
    Association between polygenic risk for schizophrenia and retinal morphology: A cross-sectional analysis of the United Kingdom Biobank.
    Psychiatry Res. 2024;339:116106.
    >> Share

  170. FEKIH-ROMDHANE F, Ghrissi F, Abassi B, Loch AA, et al
    Impulsivity as a predictor of clinical and psychological outcomes in a naturalistic prospective cohort of subjects at ultra-high risk (UHR) for psychosis from Tunisia.
    Psychiatry Res. 2024;340:116090.
    >> Share

  171. COFFMAN BA, Curtis M, Seebold D, Kocsis J, et al
    Long-latency auditory evoked response amplitudes at first episode of psychosis predict six-month recovery in positive symptom severity.
    Psychiatry Res. 2024;339:116094.
    >> Share

  172. LOURENCO PJDS, Bastos TCL, Pizarro AIN, Corredeira RMN, et al
    Feasibility and effectiveness of a 24-weeks outdoor exercise program on the physical and mental health of persons with schizophrenia.
    Psychiatry Res. 2024;339:116093.
    >> Share

  173. THELWELL ELR, Dunkerley L, Goodwin R, Giacco D, et al
    Effectiveness of online social networking interventions on social isolation and quality of life of people with psychosis: A systematic review.
    Psychiatry Res. 2024;339:116088.
    >> Share

  174. BIAN Y, Kawabata R, Enwright JF, Tsubomoto M, et al
    Expression of activity-regulated transcripts in pyramidal neurons across the cortical visuospatial working memory network in unaffected comparison individuals and individuals with schizophrenia.
    Psychiatry Res. 2024;339:116084.
    >> Share

  175. SCHUTZ A, Salahuddin NH, Priller J, Bighelli I, et al
    The role of control groups in non-pharmacological randomised controlled trials of treatment-resistant schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2024;339:116069.
    >> Share

  176. SIDDI S, Ochoa S, Laroi F, Lincoln TM, et al
    A cross-national investigation of psychosis-like experiences in five European countries included in the E-CLECTIC study: Psychometric challenges in studying their measurement.
    Psychiatry Res. 2024;339:116072.
    >> Share

  177. WANNAN CMJ, Eratne D, Santillo AF, Malpas C, et al
    Plasma neurofilament light protein is differentially associated with age in individuals with treatment-resistant schizophrenia and bipolar affective disorder compared to controls.
    Psychiatry Res. 2024;339:116073.
    >> Share

  178. WILTSCHKO M
    Is grammar affected in Schizophrenia?
    Psychiatry Res. 2024;339:116061.
    >> Share

  179. CHAN SKW, Pang TSW, Tsui HKH, Suen YN, et al
    Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia.
    Psychiatry Res. 2024;337:115985.
    >> Share

    June 2024
  180. MELISSA B, Sabrina G, Charles-Edouard G, Hind Z, et al
    Clinical characteristics associated with functioning trajectories following admission to a psychiatric institution: A prospective cohort study of individuals with psychosis.
    Psychiatry Res. 2024;339:116062.
    >> Share

  181. COLIJN MA
    Genetic testing in individuals experiencing psychosis: A practical guide for psychiatrists.
    Psychiatry Res. 2024;339:116052.
    >> Share

  182. ANDERSEN HG, DellaValle B, Bogehave H, Mogensen PB, et al
    Glycocalyx shedding patterns identifies antipsychotic-naive patients with first-episode psychosis.
    Psychiatry Res. 2024;339:116037.
    >> Share

  183. NADER G, Qureshi M, Chaudhary Z, Fischer CE, et al
    Effect of personality traits, psychological resilience and life adversities on lifetime violence trajectories: A novel classification model in schizophrenia.
    Psychiatry Res. 2024;339:116044.
    >> Share

  184. CHIEN WT, Chong YY, Bressington D, McMaster CW, et al
    A randomized controlled trial of an acceptance-based, insight-inducing medication adherence therapy (AIM-AT) for adults with early-stage psychosis.
    Psychiatry Res. 2024;339:116046.
    >> Share

  185. FERRARA M, Domenicano I, Marchi A, Zaffarami G, et al
    First episode psychoses in people over-35 years old: uncovering potential actionable targets for early intervention services.
    Psychiatry Res. 2024;339:116034.
    >> Share

  186. POUSA E, Brebion G, Lopez-Carrilero R, Ruiz AI, et al
    Predictors of clinical insight in first-episode psychosis: Different patterns in men and women.
    Psychiatry Res. 2024;339:116036.
    >> Share

  187. HOSTALET N, Gonzalez A, Salgado-Pineda P, Gonzalez-Colom R, et al
    Face-brain correlates as potential sex-specific biomarkers for schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;339:116027.
    >> Share

  188. BUCCI S, Berry N, Ainsworth J, Berry K, et al
    Effects of Actissist, a digital health intervention for early psychosis: A randomized clinical trial.
    Psychiatry Res. 2024;339:116025.
    >> Share

  189. CHENG KY, Robinson N, Ploner A, Kuja-Halkola R, et al
    Impact of traumatic brain injury on risk for schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;339:115990.
    >> Share

  190. ROTELLA F, Falone A, Cassioli E, Mannucci E, et al
    The effect of differences in trial design on estimates of efficacy of olanzapine in randomized studies.
    Psychiatry Res. 2024;336:115895.
    >> Share

  191. MISHRA A, Maiti R, Ramasubbu MK, Srinivasan A, et al
    Evaluation of the pharmacodynamic interaction effect of augmentation agents with clozapine in patients with treatment-resistant schizophrenia: A simulation study of clinical data.
    Psychiatry Res. 2024;338:115989.
    >> Share

    May 2024
  192. WASTLER HM, Mengda Y, Pan X, Bornheimer LA, et al
    Trajectories of suicidal risk among individuals with first-episode psychosis: Relationship to recovery and symptoms.
    Psychiatry Res. 2024;338:115978.
    >> Share

  193. COLLINS M, Bartholomeusz C, Mei C, Kerr M, et al
    Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis.
    Psychiatry Res. 2024;337:115966.
    >> Share

  194. SANGIMINO M, Babbitt K, Lee HS, Park S, et al
    Bodily experiences of trauma and psychosis risk.
    Psychiatry Res. 2024;337:115961.
    >> Share

  195. OH H, Karcher NR, Li Verdugo J, Botello R, et al
    Ethno-racial disparities in psychosis-like experiences among students in higher education: Findings from the Healthy Minds Study 2020-2021.
    Psychiatry Res. 2024;337:115959.
    >> Share

  196. WU Y, Zhang CY, Zhang Y, Chen R, et al
    Genomic landscape and functional characterization of structural variations in schizophrenia and bipolar disorder.
    Psychiatry Res. 2024;337:115929.
    >> Share

  197. BULDUK BK, Tortajada J, Valiente-Palleja A, Callado LF, et al
    High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls.
    Psychiatry Res. 2024;337:115928.
    >> Share

    April 2024
  198. GUO H, Zhong S, Lam ST, Wang N, et al
    Trends in violent offending among people with schizophrenia: A 10-year ecological study.
    Psychiatry Res. 2024;337:115935.
    >> Share

  199. BRADLEY ER, Portanova J, Woolley JD, Buck B, et al
    Quantifying abnormal emotion processing: A novel computational assessment method and application in schizophrenia.
    Psychiatry Res. 2024;336:115893.
    >> Share

  200. SMITH LC, Mateos AC, Due AS, Bergstrom J, et al
    Immersive virtual reality in the treatment of auditory hallucinations: A PRISMA scoping review.
    Psychiatry Res. 2024;334:115834.
    >> Share

    March 2024
  201. SPINAZZOLA E, Quattrone D, Quattrone A, Murray RM, et al
    The increased incidence of psychosis during the COVID-19 pandemic in South London: The role of heavy cannabis use.
    Psychiatry Res. 2024;336:115869.
    >> Share

  202. HAMZEHPOUR L, Bohn T, Dutsch V, Jaspers L, et al
    From brain to body: exploring the connection between altered reward processing and physical fitness in schizophrenia.
    Psychiatry Res. 2024;335:115877.
    >> Share

  203. GALLEGO JA, McNamara RK, Blanco EA, Castaneda S, et al
    Evidence for cytokine dysregulation in schizophrenia spectrum disorders: A comparison of cerebrospinal fluid and blood samples.
    Psychiatry Res. 2024;335:115871.
    >> Share

  204. SEFIK E, Guest RM, Aberizk K, Espana R, et al
    Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.
    Psychiatry Res. 2024;335:115867.
    >> Share

  205. SETHI S, Wakeham D, Ketter T, Hooshmand F, et al
    Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.
    Psychiatry Res. 2024;335:115866.
    >> Share

  206. YANG H, Zhu D, Liu Y, Xu Z, et al
    Employing graph attention networks to decode psycho-metabolic interactions in Schizophrenia.
    Psychiatry Res. 2024;335:115841.
    >> Share

  207. KISHI T, Citrome L, Sakuma K, Iwata N, et al
    A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.
    Psychiatry Res. 2024;333:115761.
    >> Share

    February 2024
  208. GORORA ME, Dalkner N, Moore RC, Depp CA, et al
    A meta-cognitive Wisconsin Card Sorting Test in people with schizophrenia and bipolar disorder: Self-assessment of sorting performance.
    Psychiatry Res. 2024;334:115831.
    >> Share

  209. QIN K, Yu Y, Cai H, Li J, et al
    Effectiveness of mindfulness-based intervention in schizophrenia: A meta-analysis of randomized controlled trials.
    Psychiatry Res. 2024;334:115808.
    >> Share

  210. KIKUCHI Y, Komatsu H, Otsuka Y, Ito F, et al
    Effect of concomitant use of valproic acid during clozapine initiation on clozapine-induced inflammation among Japanese patients with schizophrenia.
    Psychiatry Res. 2024;334:115810.
    >> Share

  211. GOODING DC, Mohrbacher DA, Umucu E, Van Hulle CA, et al
    Ethnoracialized group differences in attitudes and knowledge about schizophrenia and willingness to engage in biomarker research: The UBIGR Study.
    Psychiatry Res. 2024;334:115776.
    >> Share

  212. HYATT AS, Mulvaney-Day N, Chow CM, Cook BL, et al
    Association between electronic nicotine product use and subsequent first episode psychosis.
    Psychiatry Res. 2024;334:115785.
    >> Share

  213. KWAK PP, Ibarra C, Hernandez A, Carrasco J, et al
    Differences in metabolic biomarkers in people with schizophrenia who are of Mexican descent compared to non-Hispanic whites.
    Psychiatry Res. 2024;334:115788.
    >> Share

  214. QUIRINO AHA, da Rocha MEC, Andrade AGM, E Souza FGM, et al
    The demonstrated association: Cannabis use and onset of psychosis in the study by Medeiros et al., refuting the reverse notion.
    Psychiatry Res. 2024;334:115771.
    >> Share

    January 2024
  215. HE R, Palominos C, Zhang H, Alonso-Sanchez MF, et al
    Navigating the semantic space: Unraveling the structure of meaning in psychosis using different computational language models.
    Psychiatry Res. 2024;333:115752.
    >> Share

  216. KOS C, Bais L, Klaasen N, Opmeer E, et al
    Effects of right prefrontal theta-burst transcranial magnetic stimulation or transcranial direct current stimulation on apathy in patients with schizophrenia: A multicenter RCT.
    Psychiatry Res. 2024;333:115743.
    >> Share

  217. YI S, Wang Q, Wang W, Hong C, et al
    Efficacy of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms and cognitive functioning in schizophrenia: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2024;333:115728.
    >> Share

  218. TOUMAIAN M, Covanis P, Mantas A, Karantinos T, et al
    Multisensory integration deficits in Schizophrenia and Autism evidenced in behaviour but not event related potentials.
    Psychiatry Res. 2024;332:115727.
    >> Share

  219. PROHENS L, Rodriguez N, Segura AG, Martinez-Pinteno A, et al
    Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk.
    Psychiatry Res. 2024;332:115722.
    >> Share

  220. JEROME L, Matanov A, Bird V, Priebe S, et al
    Comparison of subjective quality of life domains in schizophrenia, mood, and anxiety disorders; an individual patient data meta-analysis.
    Psychiatry Res. 2024;332:115707.
    >> Share

  221. CHU RST, Chong RCH, Chang DHH, Shan Leung AL, et al
    The risk of stroke and post-stroke mortality in people with schizophrenia: A systematic review and meta-analysis study.
    Psychiatry Res. 2024;332:115713.
    >> Share

  222. SETIEN-SUERO E, Ayesa-Arriola R, Pena J, Ojeda N, et al
    Premorbid adjustment as predictor of long-term functionality: Findings from a 10-year follow-up study in the PAFIP-cohort.
    Psychiatry Res. 2024;331:115674.
    >> Share

  223. MASTELLARI T, Saint-Dizier C, Fovet T, Geoffroy PA, et al
    Exploring seasonality in catatonia diagnosis: Evidence from a large-scale population study.
    Psychiatry Res. 2024;331:115652.
    >> Share

    December 2023
  224. WANG Y, Zhang X
    The role of immune inflammation in electroconvulsive therapy for schizophrenia: Treatment mechanism, and relationship with clinical efficacy: Immune-inflammation in ECT for schizophrenia.
    Psychiatry Res. 2023;332:115708.
    >> Share

  225. VGONTZAS AN, Paschalidou A, Simos PG, Anastasaki M, et al
    Impact of long-acting injectable antipsychotics vs. oral medication on relapses of patients with psychosis and bipolar disorder.
    Psychiatry Res. 2023;332:115676.
    >> Share

  226. TORREY EF
    Did the human genome project affect research on Schizophrenia?
    Psychiatry Res. 2023;333:115691.
    >> Share

  227. KIM WS, Shen J, Tsogt U, Odkhuu S, et al
    Altered thalamic volumes and functional connectivity in the recovered patients with psychosis.
    Psychiatry Res. 2023;331:115688.
    >> Share

  228. ZHOU D, Xie H, Chen L, Zhu Z, et al
    The cognitive improvement in patients with schizophrenia following low-intensity repetitive transcranial magnetic stimulation could last for 6 months: A randomized controlled trial.
    Psychiatry Res. 2023;332:115672.
    >> Share

  229. CHEN Y, Zhang L, Sun Y, Wang W, et al
    Prevalence of constipation in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2023;331:115659.
    >> Share

  230. DE MEDEIROS MW, Andrade JC, Haddad NM, Mendonca M, et al
    Cannabis use influences disorganized symptoms severity but not transition in a cohort of non-help-seeking individuals at-risk for psychosis from Sao Paulo, Brazil.
    Psychiatry Res. 2023;331:115665.
    >> Share

  231. DEAN B, Duce J, Li QX, Masters CL, et al
    Lower levels of soluble beta-amyloid precursor protein, but not beta-amyloid, in the frontal cortex in schizophrenia.
    Psychiatry Res. 2023;331:115656.
    >> Share

  232. FENG XZ, Li Z, Li ZY, Wang K, et al
    Effectiveness and safety of second-generation antipsychotics for psychiatric disorders apart from schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2023;332:115637.
    >> Share

  233. VINOGRADOV S
    Harnessing neuroplasticity.
    Psychiatry Res. 2023;330:115607.
    >> Share

  234. STAFFORD E, Jakob S, Gur RE, Corcoran CM, et al
    Securing direct stakeholder feedback to inform clinical research in serious mental illness: Results of a patient and family perspectives survey.
    Psychiatry Res. 2023;330:115574.
    >> Share

    November 2023
  235. GROENING JM, Denton E, Parvaiz R, Brunet DL, et al
    A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2023;331:115626.
    >> Share

  236. LAMANNA-RAMA N, Romero-Miguel D, Casquero-Veiga M, MacDowell KS, et al
    THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation.
    Psychiatry Res. 2023;331:115643.
    >> Share

  237. WEI Z, Wang Y, Hu L, Wang Y, et al
    Incidence, prevalence, and mortality of schizophrenia from 2016 to 2020 in Shandong, China.
    Psychiatry Res. 2023;331:115612.
    >> Share

  238. LEE J, Xue X, Au E, McIntyre WB, et al
    Central insulin dysregulation in antipsychotic-naive first-episode psychosis: In silico exploration of gene expression signatures.
    Psychiatry Res. 2023;331:115636.
    >> Share

  239. CUESTA MJ, Gil-Berrozpe GJ, Sanchez-Torres AM, Moreno-Izco L, et al
    20-Year trajectories of six psychopathological dimensions in patients with first-episode psychosis: Could they be predicted?
    Psychiatry Res. 2023;331:115614.
    >> Share

  240. HU Q, Jiao X, Zhou J, Tang Y, et al
    Low-frequency repetitive transcranial magnetic stimulation over the right orbitofrontal cortex for patients with first-episode schizophrenia: A randomized, double-blind, sham-controlled trial.
    Psychiatry Res. 2023;330:115600.
    >> Share

  241. BOGE K, Hallford DJ, Pillny M
    Mindfulness, psychological flexibility and their relationship with psychopathology in persons with schizophrenia-spectrum-disorders and healthy controls - A multicenter cross-sectional study.
    Psychiatry Res. 2023;330:115591.
    >> Share

  242. DAZZAN P
    Disentangling psychosis: The challenges of informing precision medicine for what is not a single disorder.
    Psychiatry Res. 2023;330:115596.
    >> Share

  243. BERNARDIN F, Gauld C, Martin VP, Laprevote V, et al
    The 68 symptoms of the clinical high risk for psychosis: Low similarity among fourteen screening questionnaires.
    Psychiatry Res. 2023;330:115592.
    >> Share

  244. CORNBLATT BA, McFarlane WR, Carrion RE
    Authors' reply to comments on: Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns.
    Psychiatry Res. 2023;330:115594.
    >> Share

  245. KIRSHENBAUM AP, Sofis MJ, Slade M
    Response to recreational cannabis use over time in individuals at clinical high risk for psychosis: lack of associations with symptom, neurocognitive, functioning, and treatment patterns by Carrion et al., 2023.
    Psychiatry Res. 2023;330:115589.
    >> Share

  246. PARK S
    Schizophrenia in the mind, the brain and the body.
    Psychiatry Res. 2023;329:115547.
    >> Share

    October 2023
  247. BIRONG CHEN, Tan XW, Tor PC
    The impact of the number of previous illness episodes on early response to electroconvulsive therapy (ECT) in psychosis, mania, depression, psychotic depression, and catatonia: A naturalistic transdiagnostic analysis.
    Psychiatry Res. 2023;330:115580.
    >> Share

  248. KIM HK, Goncalves VF, Husain MI, Muller DJ, et al
    Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia.
    Psychiatry Res. 2023;330:115563.
    >> Share

  249. LIN CH, Huang CJ, Lin TC, Chan HY, et al
    Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021.
    Psychiatry Res. 2023;330:115575.
    >> Share

  250. WANG P, Jiang Y, Hoptman MJ, Li Y, et al
    Structural-functional connectivity deficits of callosal-white matter-cortical circuits in schizophrenia.
    Psychiatry Res. 2023;330:115559.
    >> Share

  251. VAN DER TUIN S, Booij SH, Muller MK, van den Berg D, et al
    The added value of daily diary data in 1- and 3-year prediction of psychopathology and psychotic experiences in individuals at risk for psychosis.
    Psychiatry Res. 2023;329:115546.
    >> Share

  252. HASSAN L, Eisner E, Berry K, Emsley R, et al
    User engagement in a randomised controlled trial for a digital health intervention for early psychosis (Actissist 2.0 trial).
    Psychiatry Res. 2023;329:115536.
    >> Share

  253. SCHLIEF M, Rich N, Rains LS, Baldwin H, et al
    Ethnic differences in receipt of psychological interventions in Early Intervention in Psychosis services in England - a cross-sectional study.
    Psychiatry Res. 2023;330:115529.
    >> Share

  254. ZHANG T, Xu L, Wei Y, Tang X, et al
    Duration of untreated prodromal psychosis among individuals with clinical high risk for psychosis.
    Psychiatry Res. 2023;329:115522.
    >> Share

    September 2023
  255. SAMPEDRO A, Pena J, Sanchez P, Ibarretxe-Bilbao N, et al
    Moderators of functional improvement after integrative cognitive remediation in schizophrenia: Toward a personalized treatment approach.
    Psychiatry Res. 2023;329:115495.
    >> Share

  256. HUI CLM, Wong CCL, Chan EWT, Suen YN, et al
    COVID-19 exposure and psychosis: A comparison of clinical, functional, and cognitive profiles in remitted patients with psychosis.
    Psychiatry Res. 2023;328:115487.
    >> Share

  257. CAMPRODON-BOADAS P, De la Serna E, Plana MT, Flamarique I, et al
    Delusional beliefs in adolescents with anorexia nervosa, obsessive-compulsive disorder, or first-episode psychosis: A comparative study.
    Psychiatry Res. 2023;328:115490.
    >> Share

  258. BALDINI V, Stefano RD, Rindi LV, Ahmed AO, et al
    Association between adverse childhood experiences and suicidal behavior in schizophrenia spectrum disorders: A systematic review and meta-analysis.
    Psychiatry Res. 2023;329:115488.
    >> Share

  259. GEBREEGZIABHERE Y, Habatmu K, Cella M, Alem A, et al
    Introducing an interview-based cognitive assessment tool for people with Schizophrenia in Ethiopia.
    Psychiatry Res. 2023;328:115474.
    >> Share

  260. SANCHEZ-TORRES AM, Garcia de Jalon E, Gil-Berrozpe GJ, Peralta V, et al
    Cognitive intraindividual variability, cognitive impairment and psychosocial functioning in first-episode psychosis patients.
    Psychiatry Res. 2023;328:115473.
    >> Share

  261. FORDHAM E, Gao CX, Filia K, O'Donoghue B, et al
    Social disadvantage in early psychosis and its effect on clinical presentation and service access, engagement and use.
    Psychiatry Res. 2023;328:115478.
    >> Share

  262. MAURUS I, Roell L, Lembeck M, Papazova I, et al
    Exercise as an add-on treatment in individuals with schizophrenia: Results from a large multicenter randomized controlled trial.
    Psychiatry Res. 2023;328:115480.
    >> Share

  263. INCHAUSTI L, Gorostiza I, Gonzalez Torres MA, Oraa R, et al
    The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use.
    Psychiatry Res. 2023;328:115475.
    >> Share

  264. FANG X, Gao C, Wu W, Hu X, et al
    The role of the gut microbiome in weight-gain in schizophrenia patients treated with atypical antipsychotics: Evidence based on altered composition and function in a cross-sectional study.
    Psychiatry Res. 2023;328:115463.
    >> Share

  265. ZHANG J, Yang Y, Liu T, Shi Z, et al
    Functional connectivity in people at clinical and familial high risk for schizophrenia.
    Psychiatry Res. 2023;328:115464.
    >> Share

  266. SMITH ECC, Au E, Pereira S, Sharma E, et al
    Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review.
    Psychiatry Res. 2023;328:115472.
    >> Share

  267. LUCKHOFF HK, Asmal L, Smit R, Phahladira L, et al
    Sex, gender, and outcome in first-episode psychosis: The role of premorbid functioning.
    Psychiatry Res. 2023;328:115460.
    >> Share

  268. SEGAL SP, Rimes L, Badran L
    Crime and victimization outcomes following civil rights limits to the use of compulsory treatment.
    Psychiatry Res. 2023;327:115377.
    >> Share

  269. JOSHI YB, Gonzalez CE, Molina JL, MacDonald LR, et al
    Mismatch negativity predicts initial auditory-based targeted cognitive training performance in a heterogeneous population across psychiatric disorders.
    Psychiatry Res. 2023;327:115215.
    >> Share

  270. XIE Y, Guan M, Wang Z, Ma Z, et al
    Alterations in brain connectivity patterns in schizophrenia patients with auditory verbal hallucinations during low frequency repetitive transcranial magnetic stimulation.
    Psychiatry Res. 2023;328:115457.
    >> Share

    August 2023
  271. CARRION RE, Auther AM, McLaughlin D, Adelsheim S, et al
    Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns.
    Psychiatry Res. 2023;328:115420.
    >> Share

  272. JOHANSSON M, Hjarthag F, Helldin L
    Exploring cross-sectional and longitudinal symptomatic remission and subjective quality of life in schizophrenia.
    Psychiatry Res. 2023;328:115421.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016